Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications
Author
Summary, in English
The hematopoietic stem cell (HSC) is the prototype organ-regenerating stem cell (SC), and by far the most studied type of SC in the body. Currently, HSC-based therapy is the only routinely used SC therapy; however, advances in the field of embryonic SCs and induced pluripotent SCs may change this situation. Interest into in vitro generation of HSCs, including signals for HSC expansion and differentiation from these more primitive SCs, as well as advances in other organ-specific SCs, in particular the intestine, provide promising new applications for SC therapies. Here, we review the basic principles of different SC systems, and on the basis of the experience with HSC-based SC therapy, provide recommendations for clinical application of emerging SC technologies. Leukemia (2011) 25, 1095-1102; doi:10.1038/leu.2011.52; published online 29 April 2011
Department/s
Publishing year
2011
Language
English
Pages
1095-1102
Publication/Series
Leukemia
Volume
25
Issue
7
Document type
Journal article review
Publisher
Nature Publishing Group
Topic
- Cancer and Oncology
Keywords
- stem cell
- iPS
- gene therapy
- embryonic stem cell
- transplantation
Status
Published
ISBN/ISSN/Other
- ISSN: 1476-5551